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We studied the interaction of RV with human peripheral blood mononuclear cells (PBMC) from adult volunteers. After exposure of PBMC to
rhesus RV (RRV), T and B lymphocytes, NK cells, monocytes, and myeloid and plasmacytoid dendritic cells expressed RV non-structural
proteins, at variable levels. Expression of these RV proteins was abolished if infection was done in the presence of anti-VP7 neutralizing
antibodies or 10% autologous serum. Supernatants of RRV exposed PBMC contained TNF-α, IL-6, IFN-α, IFN-γ, IL-2 and IL-10. Plasmacytoid
DC were found to be the main source of IFN-α production, and in their absence the production of IFN-γ and the frequency of RV specific T cells
that secrete IFN-γ diminished. Finally, we could not detect RV-antigen associated with the PBMC or expression of RV non-structural proteins in
PBMC of acutely RV-infected children. Thus, although PBMC are susceptible to the initial steps of RV infection, most PBMC of children with
RV-gastroenteritis are not infected.
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Rotavirus (RV) is the single most important etiological agent
of severe gastroenteritis (GE) in children (Parashar et al., 2003,
2006). Although two new RV vaccines have been recently
licensed, improvement of these vaccines and development of
future RV vaccines is hampered by our limited knowledge of the
mechanisms that mediate immunity against RV in humans
(Franco et al., 2006).
The way RV antigen is presented to stimulate naive T cells
or re-stimulate memory T cells is poorly understood. Given
that RV predominantly infects and replicates in enterocytes,
dendritic cells (DC) present in the intestine are probably the
initial RV-antigen presenting cells (APCs). However, despite⁎ Corresponding author. Fax: +57 1 2850356.
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doi:10.1016/j.virol.2007.04.007its “enteric nature”, RV antigen, dsRNA and infectious
particles have been found in blood of children and systemic
organs in animals (Azevedo et al., 2005; Blutt and Conner,
2007; Blutt et al., 2003, 2006; Crawford et al., 2006; Fenaux
et al., 2006; Fischer et al., 2005; Nakagomi and Nakagomi,
2005; Ray et al., 2006). For this reason, a systemic immune
response to RV is expected.
As an initial step to try to understand how RV interacts
with systemic APCs, we studied monocyte-derived DC
(moDC) exposed to RV (Narvaez et al., 2005). MoDC are
considered a model for studying human myeloid DC (mDC).
We found that while very low numbers of immature moDC
expressed NSP4, up to 46% of mature moDC expressed
NSP4, indicating that at least the initial steps of viral infection
can occur in moDC. Moreover, our results suggested that
although RV can promote the capacity of moDC to prime
naive cells to become Th1 cells, it does not seem to be a
strong stimulus to make efficient APCs, leaving unclear their
role in viral antigen presentation.
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mononuclear cells (PBMC) from healthy adults exposed to
rhesus RV (RRV) became infected, and the pattern of
cytokines secreted by these cells. We also assessed the role
of plasmacytoid DC (pDC), in the RRV exposed PBMC
cultures, as a source of IFN-α and in stimulating RV-specific
memory T cells. Finally, we explored if PBMC from RV-
infected children are associated with RV antigen and/or express
RV NSPs.
Results
Human PBMC are susceptible to the initial steps of infection
with RV
To determine if RVs have the potential to infect PBMC, cells
from healthy adult volunteers were exposed to purified RRV
(MOI=5) or a Mock control preparation during 0–48 h. We
evaluated the presence of the viral protein NSP4 in T, B, NK
cells, monocytes, mDC and pDC by flow cytometry, as an
indicator of the initial infectious process. Expression of NSP4
was detected 4 h post infection (PI) in all cells analyzed (Fig. 1),
with the highest frequencies observed in B cells, monocytes and
DC. At 8 h PI, similar percentages of T, B and NK cellsFig. 1. Expression of RV NSP4 by RRVexposed human PBMC. Intracellular NSP4 e
of human PBMC to purified RRV (MOI=5) during 4 h. The number in the quad
representative of 2–4 independent experiments.expressing NSP4 were observed, while the frequencies of
monocytes, mDC and pDC expressing NSP4 tended to decrease
(Fig. 2). Additional experiments showed similar levels of NSP4
expression in T (n=5), B (n=8) and NK (n=3) cells exposed to
RRV in the form of unpurified tissue culture supernatant (data
not shown). Exposure of PBMC to both unpurified RRVand the
Mock control preparation (but not with the purified RRVand its
control preparation) induced changes in the phenotype of
monocytes and DC, precluding their analysis (data not shown).
In addition, in 5 experiments the staining pattern of B cells with
anti-NSP2, another RV NSP, was similar to that observed with
anti-NSP4 (data not shown).
To determine if the initial steps of viral infection could
also occur in PBMC with a homologous human RV, PBMC
were exposed to partially purified Wa (MOI=5) and a Mock
control for 0 to 8 h. NSP4 expression was seen in Wa treated
B cells (n=4) but not T (n=5) or NK cells (n=3). The
frequency of B cells expressing NSP4 after infection with Wa
was from 3.5 to 12 times lower than after infection with RRV
(Fig. 3B). In addition, the percentages of expression of NSP4
and NSP2 in B cells infected with Wa were similar (data not
shown). In conclusion, several subsets of PBMC, especially B
cells, monocytes and DC, are susceptible to the initial steps of
RV infection.xpression was observed in T, B, NK cells, monocytes (M) and DC after exposure
rant represents the percentage of NSP4+ cells for each cell subset. Data are
Fig. 2. Differential expression of RV NSP4 among different human PBMC subpopulations at different times PI. PBMC from healthy adult volunteers (n=2–5) were
exposed to purified RRV (MOI=5) during 0–48 h. Shown are net values and medians for the % NSP4+ cells in each subset. Less than 1.1% background cells
expressed NSP4 in Mock treated control PBMC.
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expression of NSPs by PBMC
To determine if neutralizing antibodies can block the
expression of NSPs by PBMC exposed to RV, cells were
infected with purified RRV for 4 h in the presence of the
neutralizing anti-VP7 monoclonal antibody (MAb) 159 or an
isotype control MAb. A decrease in viral NSP4 protein
expression was observed in all cellular subpopulations
analyzed (Fig. 3A). Similarly, although to a lesser degree,
the pretreatment of PBMC with 10% autologous serum
showed inhibition of RRV infection (Fig. 3A). However, we
observed that the inhibition induced by autologous serum was
somewhat variable between volunteers studied (compare Fig.
3A and B performed with cells from different volunteers), this
is probably due to differences in their levels of RV neutralizing
antibodies. Similar results were observed for T, B and NK cells
exposed to RRV tissue culture supernatant for 8 h (n=3; Fig.
3B, and data not shown). MAb 159 (homotypic for G3, but
partially cross-reactive with serotype G1 viruses at high doses)
induced limited inhibition of NSP4 expression by B cellsexposed to Wa, while MAb 2C9 (homotypic for G1 viruses)
and 10% autologous serum drastically reduced the expression
of NSP4 in B cells exposed to this same virus (Fig. 3B). Thus,
the initial steps of infection of PBMC by RV are efficiently
neutralized by human serum and classical neutralizing anti-
VP7 antibodies.
PBMC exposed to RV initially secrete TNF-α, IL-6, and IFN-α
followed by IL-2, IFN-γ and IL-10
To determine the pattern of cytokines secreted by PBMC
exposed to RV, we collected supernatants from both Mock and
purified RRV treated PBMC cultures and evaluated the
presence of: IL-12p70, TNF-α, IL-6, IL-1β, IL-8, IFN-α; IL-
2, IFN-γ; IL-4, IL-5, IL-10 and TGF-β. Four hours PI, PBMC
secreted significant amounts of IFN-α, TNF-α and IL-6. Forty-
eight hours PI TNF-α levels returned to baseline, while IL-6 and
IFN-α levels remained constant. IFN-γ secretion was detected
by 8 h PI and reached the highest levels by 48 h PI. Low levels
of IL-2 and IL-10 were observed at 24 h PI and a modest
increase was seen by 48 h PI (Fig. 4). Increases in IL-12p70, IL-
Fig. 3. Anti-VP7 MAbs and autologous serum inhibit early steps of RV infection by PBMC. (A) PBMC from healthy adult volunteers were exposed to purified RRV
(MOI=5) for 4 h, in the presence anti-VP7 MAb 159 or 10% autologous serum. Data are expressed as percentage of inhibition compared with cells not exposed to the
inhibitors. This result is representative of two independent experiments. (B) PBMCwere exposed to either RRV (top row dot plots) or Wa (bottom dot plots) at an MOI
of 5 during 8 h in the presence of an isotype control (IgG1κMAb), anti-VP7 MAbs 159 or 2C9 or 10% autologous serum. The numbers in the upper quadrants are the
percentage of B cells expressing NSP4. One of three representative experiments using MAb 159 and autologous serum is shown.
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shown). Small increases in IL-8 and latent TGF-β were
observed in RRV exposed PBMC, but the significance of
these findings are uncertain because of the relatively high levels
of these cytokines present in control treated PBMC (data not
shown). In the above experiments, PBMC were simultaneously
treated with SEB and CpG 2395, as positive controls. As
expected, SEB induced pro-inflammatory, Th1 and Th2
cytokines. CpG 2395 induced all pro-inflammatory cytokines,
except IL-12p70 and IL-1β; it did not induce detectable levels
of IL-2, IFN-γ or Th2 cytokines, and only a very modest
secretion of IL-10 (data not shown).
pDC are the principal source of IFN-α produced by PBMC
exposed to RV and are associated with the induction of IFN-γ
IFN-α is one of the most important cytokines induced during
the course of viral infections (Liu, 2005). Many blood cells can
produce IFN-α, but pDCs have been shown to be the principal
source (Ito et al., 2006; Liu, 2005; Siegal et al., 1999). Todetermine if pDC were contributing to the IFN-α produced by
RV stimulated PBMC, we stimulated PBMC, depleted or not of
pDC, with RRV. Depletion of pDC in these experiments was
above 91%. Secretion of IFN-α was reduced by over 95% in
pDC-depleted PBMC (Fig. 5A). Importantly, the levels of IFN-
γ were also reduced (median=80.6%; range 55.4–96.1%) in
these supernatants (Fig. 5B). Levels of IFN-α and IFN-γ were
not reduced in control PBMC depleted of B cells or treated with
GAM-coated beads (data not shown).
To confirm and extend the previous results, we studied the
simultaneous presence of intracellular NSP4 protein and of
IFN-α in pDC collected from PBMC exposed to RRV. Most
pDC (Fig. 6) neither expressed NSP4 nor secreted IFN-α (range
45–79%; n=3). A small fraction (0.6 to 12.9%; n=3) of pDC
expressed NSP4 and secreted IFN-α. In addition, pDC that
secreted IFN-α, but did not express NSP4 (from 4.5 to 19.4%;
n=3) and pDC that expressed NSP4 but did not secrete IFN-α
(from 9.4 to 35.4%; n=3) were also observed. Thus, both
infected and non-infected pDC seem to be the main source of
IFN-α when PBMC are exposed to RV.
Fig. 4. Cytokines secreted by PBMC exposed to RRV. Supernatants collected from PBMC exposed to purified RRV (MOI=5) for 0–48 h were evaluated by CBA and
ELISA for pro-inflammatory, Th1, Th2 and Treg cytokines. Shown are net values and medians from RRV treated cells (n=3).
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Because depletion of pDC from PBMC also diminished their
capacity to secrete IFN-γ (Fig. 5B), we addressed the involvement
of circulating pDC in the stimulation of IFN-γ secreting RV-
specific memory T cells. For this purpose, we stimulated total and
pDC-depleted PBMC with RRV (MOI=5) in a short term (10 h)
assay. As shown in Fig. 7, pDC depletion was associated with a
significant decrease in the frequency of RV-specific CD4+
(median non-depleted PBMC=0.15%, range=0.05–0.25% vs.
median depleted PBMC=0.04%, range=0.0–0.09%, n=7, Wil-
coxon test p=0.01) and CD8+ (median non-depleted PBMC=
0.07%, range=0.01–0.19% vs. median depleted PBMC=0.01%,
range=0.0–0.16%, n=7, Wilcoxon test p=0.03) T cells that
secrete IFN-γ. Control PBMC depleted of B cells or treated
with GAM-coated beads did not show reductions in the
numbers of RV-specific T cells (data not shown).
PBMC from children with RV GE are not infected with RV
To determine if wild type RV could be infecting or be
associated with PBMC in vivo, we evaluated RV-antigen in
plasma and PBMC of 17 children with acute GE (Table 1). Three
groups of children were studied: Children in group I (GI) did nothave RVantigen/RNA in feces or plasma (n=2); Group II (GII)
children had RVantigen and/or RNA in feces but not in plasma
(n=6); andGroup III (GIII) children had RVantigen and/or RNA
in feces and plasma (n=9). No differences were seen in the time
after onset of diarrhea, episodes of vomit or diarrhea per day
between children of GII and GIII. The median age of children in
GII (11.5 months range: 3–14 months) was significantly lower
than that (median 17 months range: 10–20 months) of children
in GIII (Mann–Whitney p=0.017), a tendency previously
observed (Ray et al., 2006). Only three children, one from GI
and two from GII, had evidence of previous exposure to RV,
indicated by the presence of circulating RV specific IgA in
plasma. Among the RV+ stool samples, the P[8] genotype was
the most frequently detected (12/15), while P[6] (2/15) and P[4]
(1/15) RV were also identified.
Compatible with previous observations (Fischer et al., 2005;
Ray et al., 2006), ELISAODs for RV-antigen in feces and plasma
tended to correlate (Spearman rho: 0.84 p=0.05) for GIII
children. We were not able to detect RV-antigen by ELISA in
lysates of PBMC from three children from GII and four children
fromGIII (data not shown). Furthermore, with the flow cytometry
assay used above to identify initial steps of infection of adult
PBMC in vitro, we did not detect intracellular NSP4 in the T cells
and B cells (n=16; 2/GI, 6/GII, 8/GIII) or monocytes (n=8;
Fig. 5. pDC are the main source of IFN-α in PBMC exposed to RV. (A) pDC
depleted PBMC (5×106) were exposed to Mock or purified RRV (MOI=5) for
48 h, and supernatants were collected to measure IFN-α by ELISA. (B) IFN-γ
levels from the same supernatants were evaluated by CBA. CpG 2395 0.038 μM
was used as positive control for IFN-α secretion by pDC (n=3). Individual and
median values are shown.
Fig. 7. Human pDC are necessary for efficient stimulation of IFN-γ secreting
RV memory T cells. Total, and pDC depleted PBMC (2×106/2 ml) were
exposed to RRV lysate (MOI=5) or Mock control in the presence of anti-CD28
and anti-CD49d MAbs for 10 h. Brefeldin A was added during the last 5 h.
Intracellular IFN-γ was determined in CD69+ activated CD4+ and CD8+ T
cells. Bars represent the median (n=7).
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(n=12; 2/GI, 4/GII, 6/GIII) or pDC (n=4; 4/GIII). Staining for
intracellular expression of RV-NSP2 was also negative in T
cells, B cells and monocytes from 3 children studied
simultaneously for NSP4 expression (1/GII and 2/GIII).
In conclusion, we could not detect RV antigen associated
with PBMC of children with acute RV infection either by
ELISA, or using the same flow cytometry assay with which weFig. 6. NSP4+ and NSP4− human pDC secrete IFN-α. PBMC were exposed to pur
simultaneous detection of intracellular NSP4 and IFN-α. (A) pDCs were gated (R2)
(C) Staining of pDC (R2) with antibodies to IFN-α+ and NSP4+. The numbers in
independent similar experiments.could detect infection of adult PBMC using high MOIs of tissue
culture adapted RV.
Discussion
Wehave studied the interaction of RVwith PBMC and shown
that: (i) RVentered and directed in vitro the synthesis of NSP in
several PBMC subsets, particularly in B, monocytes cells and
DC; (ii) expression of NSPs was blocked by neutralizing
antibodies against VP7 and autologous serum; (iii) RRVinduced
PBMC to initially secrete pro-inflammatory cytokines (IL-6,
TNF-α and IFN-α) and subsequently Th1/regulatory cytokines
(IFN-γ, IL-2 and IL-10); (iv) the main source of the IFN-α were
pDC; (v) the presence of pDC seems critical to stimulate IFN-γ
secreting RV-memory T cells, and (vi) RV antigen present in
blood of RV infected children is not associated with PBMC, and
their PBMC do not express RV NSPs.
The relatively higher infection of B cells and DC that we
found, compared to T cells, (Figs. 1 and 2) is consistent withified RRV (MOI=5) for 8 h, in the presence of Brefeldin A in the last 3 h, for
as HLA-DRint/CD123high. (B) Staining of pDC (R2) with isotype control MAbs.
the quadrants are the percentage of positive cells. Data are representative of 3
Table 1
Study population
Group Age a HAODb Diarrhea c Vomit d Plasma
IgA e
RV Ag (% of positive Control) RV P
genotype
Feces Plasma PBMC
I 13 192 7 7 100 0.0 0.0 ND Neg
I 5 24 3 1 Neg 0.0 0.0 ND Neg
II 6 72 6 0 Neg 0.9 0.0 0 P[8]
II 12 30 18 15 800 19.0 0.0 ND P[8]
II 14 144 5 5 Neg 56.7 0.0 ND P[8]
II 14 240 8 7 1600 87.0 0.0 0 P[8]
II 11 120 15 5 Neg 90.9 0.0 0 P[8]
II 3 16 4 2 Neg 94.5 0.0 ND P[8]
III 20 11 3 5 Neg 84.5 55.3 ND P[8]
III 10 30 7 6 Neg 87.3 78.9 ND P[8]
III 16 48 10 4 Neg 88.9 93.6 0 P[6]
III 16 48 10 8 Neg 92.2 90.0 ND P[8]
III 18 36 3 5 Neg 94.7 100.6 0 P[4]
III 20 96 1 4 Neg 96.0 85.0 0 P[6]
III 17 48 8 3 Neg 97.0 89.8 0 P[8]
III 18 24 12 12 Neg 97.6 89.3 ND P[8]
III 11 72 5 4 Neg 115.0 120.0 ND P[8]
Neg: not detectable. ND: not done.
a Age of the children in months.
b Hours after onset of diarrhea.
c Maximum number of diarrhea episodes per day.
d Maximum number of vomit episodes per day.
e Reciprocal of IgA titer.
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NSP4-positive cells were found expressing either B220 (a B-
cell marker also found on pDC), CD11c (a mDC marker) or
CD11b (a marker expressed on macrophages, NK cells,
granulocytes, and activated lymphocytes), but not in CD3+ T
cells (Fenaux et al., 2006). The factors that determine the
relative susceptibility to infection of the different subsets of
PBMC are unknown. In our previous publication we showed
that RV infected higher numbers of mature than immature
moDC (Narvaez et al., 2005). Since mature moDC express
higher levels of the α4 integrin than immature moDC, and
this integrin has been shown to be one of the receptors for
RV (Lopez and Arias, 2006), we hypothesized that this could
be a possible explanation. Because both B and T cells
express on average the same levels of the α4 integrin (Rott
et al., 2000), other factors seem necessary to explain their
differential susceptibility to infection.
In contrast to our in vitro data, RVNSPs could not be detected
in PBMC from RV-infected children. This is most likely due to
the neutralizing capacity of factors (antibodies, cytokines, etc.)
present in serum (Fig. 3), and/or to the low levels of infectious
virus circulating in blood (Ray et al., 2006). It may also be that
human RVs, like theWa virus we have evaluated (Fig. 3), have a
lower capacity to infect PBMC than RRV that has been shown to
have a broad tissue tropism (Crawford et al., 2006). Finally, RV
infection of PBMC seems to be transient (Fig. 2) and it is also
possible that only abortive infections are present in these cells.
However, we can not rule out that low levels of infection are
occurring in selected subpopulation of PBMC of infected
children. This is particularly true for the pDC, which are present
at low levels in the children evaluated.Of note, cellular viability in the cultures of PBMC treated
with RRV (evaluated by trypan blue exclusion) was higher
than 90%. However, 24 h post-treatment important reductions
in the relative frequencies of monocytes and DC were
observed in both the RV and control treated cultures. For this
reason, we did not evaluate infection in these subpopulations
of PBMC past this time (Fig. 2). This finding is expected due
to the known dependence of these cells on specific growth
factors for survival. In our previous publication we showed
that RRV did not induce cell death of human moDC (Narvaez
et al., 2005). From our present results it is difficult to asses if
RV is inducing cell death of monocytes and/or DC, and future
experiments are needed to determine if this is the case.
Studies to establish if RV is performing a complete replicative
cycle in any of the PBMC subsets studied will also shed light
on the way RV interacts with PBMC. Nevertheless, this seems
unlikely since in human moDC (Narvaez et al., 2005) and
murine mDC (Douagi et al., 2007) only very low levels or
not complete RV replication is seen.
PBMC exposed to RRV initially secreted IL-6, TNF-α and
IFN-α but no IL-12, and in a second phase they secrete IFN-
γ and small amounts of IL-2 and IL-10 (Fig. 3). This pattern
of secreted cytokines is concordant with that detected in the
serum of RV infected children (Dubos et al., 2004; Jiang et
al., 2003), suggesting that PBMC maybe contributing to the
production of these cytokines. Moreover, it suggests the
induction of a Th1 type T cells by a pathway dependent on
IFN-α and not of IL-12 (Liu, 2005). This interpretation is in
agreement with our previous study showing only low levels
of secretion of IL-12 by mature human moDC exposed to
RRV (Narvaez et al., 2005). As dsRNA activated mDC (but
181M.C. Mesa et al. / Virology 366 (2007) 174–184not pDC (Ito et al., 2006)) are the principal source of IL-12 in
viral infections, the absence of this cytokine suggests that RV
dsRNA is not available to stimulate TLR-3 in immature mDC
(Matsumoto et al., 2003). However, these findings contrast
with results in which cultures of simian moDC treated with
RV and T cells secrete IL-12 (Sestak et al., 2004). Thus,
under certain circumstances RV may stimulate an IL-12
milieu that could induce Th1 T cells.
The high levels of IFN-α we observed in the cultures of
PBMC exposed to RRV is somewhat at odds with studies that
have shown that in the intestinal epithelial cell line, Caco-2,
RV NSP1 can induce degradation of IFN regulatory factor 3
and 7, which are key to produce IFN-α (Barro and Patton,
2005, 2007). Nonetheless, they are consistent with recent
results in the mouse model where mDC and pDC, but not
fibroblasts, exposed to RV secrete IFN-α (Douagi et al.,
2007). Thus, the inhibitory effect of NSP1 on the production
of IFN-α seems to be less efficient in DC infected with RV.
However, as shown in the murine model, NSP1 could be
down-regulating some production of IFN-α in DC (Douagi et
al., 2007). We observed that a group of non-infected pDC
produced IFN-α and that only a minority of infected pDC
were secreting IFN-α (Fig. 5). This result suggests that some
of the IFN-α secreting pDC maybe activated by bystander
mechanisms, and that RV may have the capacity to inhibit
IFN-α in a subset of infected pDC.
The quantity of IFN-γ (Fig. 5) and the frequency of RV
specific T cells (Fig. 7) secreting IFN-γ were diminished in
cultures of PBMC depleted of pDC, indicating a role for pDC
in stimulating RV-specific memory T cells. In agreement with
this finding, it has been shown that pDC can directly
stimulate memory T cells specific for influenza virus
(Fonteneau et al., 2003). On the other hand, pDC could
also be fulfilling an indirect role in stimulating the T cell by
“helping” mDC to present viral antigen, as has been shown in
the mouse model for HSV (Yoneyama et al., 2005) or in a
murine model of tumor immunity (Lou et al., 2007). Of note,
the involvement of pDC in RV antigen presentation would
suggest that they may induce naive T cells to become IL-10-
secreting regulatory T cells (Ito et al., 2007), and/or favor the
re-stimulation of memory T cells that also secrete this
cytokine (Janke et al., 2006). In spite of this, we have not
evidenced RV-specific T cells that secrete IL-10, in our short
term (10 h) re-stimulation protocol of PBMC (Narvaez et al.,
2005). It remains to be determined if the low levels of IL-10
produced late in cultures of RV stimulated PBMC (Fig. 4) are
produced by regulatory T cells.
In conclusion, we have performed studies of the interaction
of RV with PBMC cells that may potentially shed light on
characteristics of the systemic anti-RV immune response. The
lack of infection of PBMC from RV infected children with
antigenemia suggests that infectious RV is not the principal
antigen being presented systemically to T cells. This may be an
important factor that determines the repertoire of systemic RV-
specific T cells. Future studies are necessary to establish the
relevance of our results suggesting a role for pDC in stimulating
RV-specific memory T cells to the in vivo situation in children.Materials and methods
Subjects and sample collection
Fourteen healthy adults (21–42 years old), and 17
children (2–24 months old) admitted with gastroenteritis to
the pediatric emergency service of the San Ignacio Hospital
in Bogotá (Colombia) were enrolled in this study. All adults
and children's parents/guardians signed an informed consent
approved by the Ethics Committee of the Medical School of
the Pontificia Universidad Javeriana. Blood samples were
drawn from volunteers to obtain serum and/or plasma and
PBMC. Stool samples were collected only from children,
and kept at −70 °C until use. PBMC were isolated by
density gradient using Lymphosep medium (d=1.077) (ICN
Biomedical Inc, Irvine, CA). The cells were then washed,
resuspended in AIM-V media (Gibco, Grand Island, NY)
and used immediately. For some experiments, we added
150 μl of PBS to a pellet of 3–5×106 PBMC isolated from
children and cells were lysed by three freeze–thaw cycles
(PBMC lysate). These lysates were centrifuged at 16,000×g
for 5 min at 4 °C and supernatants stored at −70 °C until
analysis.
Viruses and cells
The RRV strain of simian RV (obtained from Dr. H. B.
Greenberg, Stanford University CA) was treated with 2 μg/ml
trypsin (Sigma, St. Louis, MO) for 15 min at 37 °C and then
grown in MA104 cells in the presence of 1 μg/ml trypsin for
48 h at 37 °C (Jaimes et al., 2002). Cells were lysed by
repeated freezing and thawing, and RV was purified by
ultracentrifugation in CsCl gradient (Jaimes et al., 2002). The
purified stock virus preparations had titters between 2.5×108
and 1×109 focus forming units (ffu)/ml. Before use, the virus
was dialyzed against RPMI and a fraction of this dialyzing
media was saved to be used as control (Mock control). In
some experiments, RRV was used as a clarified tissue culture
supernatant and the supernatant of Mock-infected MA104
cells was used as a control for these preparations. The human
Wa strain (G1P[8]) RV (obtained from Dr. E Mendez, UNAM
Mexico) was similarly grown in MA104, and semi-purified
on a 40% sucrose gradient. The Wa stocks used had titters
between 2 and 3×108 ffu/ml. Supernatants of MA104 cells
cultured without Wa and treated similarly were used as Mock
controls. The RNA patterns of both RV strains were
confirmed by polyacrylamide gel electrophoresis.
RV infection of PBMC
PBMC (25×106 cells) were exposed to RV (MOI=5) and its
respective Mock control for 30–45 min at 37 °C with 5% CO2.
Cells were then resuspended in 5 ml AIM-V medium (Gibco)
and distributed in 1 ml aliquotes (5×106 PBMC) in 15 ml
polypropylene tubes. Aliquots were incubated with a 5° angle
inclination at 37 °C with 5% CO2 for different periods of time.
In some experiments, 5×106 PBMC were stimulated with
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Sigma), or 0.038 μM 2395 CpG (Coley Pharmaceutical Group
Inc, Wellesley, MA), as positive controls. After incubation,
cellular suspensions were centrifuged; supernatants were
collected and kept at −70 °C for cytokine evaluation, and
cells were stained for flow cytometry analysis. In some
experiments, PBMC were infected in the presence of 10%
autologous decomplemented (30 min 56 °C) serum, RV-
neutralizing anti-VP7 MAbs (159 or 2C9 ascites, G3 and G1
specific, respectively) supplied by Harry B. Greenberg or
IgG1κ isotype control MAb (BD Bioscience, San Diego, CA).
Detection of intracellular NSP4 and NSP2 in PBMC
To establish if PBMC are permissive to RV infection, the
cells exposed to RV or Mock preparations were stained for
intracellular detection of NSP4, as previously described
(Narvaez et al., 2005), with some modifications. Cells were
resuspended in PBS–0.05 mM EDTA for 10 min and then
washed with staining buffer [0.5% BSA (Merck KGaA,
Darmstadt, Germany), 0.02% sodium azide (Mallinckrodt
Chemicals, Paris, KY) in PBS], fixed with 1% paraformalde-
hyde (Electron Microscopic Sciences, Hatfield, PA) for 5 min,
washed and permeabilized with 1× permeabilizing solution
(BD Bioscience) for 10 min at room temperature (RT). Then,
the cells were washed and FcγRs (receptors present on PBMC
and responsible for non-specific binding of immunoglobulins
to cells) were blocked with 30% autologous serum, for 10 min
at RT. Afterwards, cells were incubated with anti-NSP4 MAb
(B4-2) or, anti-NSP2 MAb (191) (both supplied by Harry B.
Greenberg) or their respective IgG2a and IgG1 isoytpe controls
(BD Biosciences) for 30 min at 4 °C. After washing the cells,
FCγRs were blocked again with 30% of a 9:1 mixture of
normal goat serum (Vector): autologus serum, for 10 min at RT.
Then, allophycocyanin labeled goat anti-mouse immunoglo-
bulin (GAM-APC, Invitrogen Molecular Probes, Eugene, OR)
was added for 30 min at 4 °C. Finally, cells were stained for
30 min at 4 °C with monoclonal antibodies specific for the
different cell subsets (all from BD Biosciences unless otherwise
noted): 1) monocytes: anti-CD14FITC, B cells: anti-CD19PE
and T cells: anti-CD3PerCP; 2) NK cells: NK cocktail (anti-
CD3FITC/anti-CD16PE/anti-CD56PE/anti-CD45PerCP); 3)
mDC: Lin-1FITC (anti-CD3/anti-CD14/anti-CD16/anti-CD56/
anti-CD19/anti-CD20)/anti-CD11cPE/anti-HLA-DRPerCP; and
4) pDC: Lin-1FITC/anti-CD123PE/anti-HLA-DRPerCP. In
some experiments anti-CD19FITC/anti-CD16PE/anti-CD56PE/
anti-CD3PerCP or anti-CD3FITC/anti-CD16PE/anti-CD56PE/
anti-CD20PECy5 (Dako) were used. Then, cells were washed
with staining buffer, resuspended in 1% paraformaldehyde in
PBS, acquired on a FACSCalibur (BD Bioscience) equipped
with a second 635-nm red diode laser, and analyzed with
Cellquest Pro software. Dead cells and debris were excluded by
forward and side scatter gating. Results are expressed as net
values: % NSP4+ cells in PBMC treated with RRV minus %
NSP4+ cells in PBMC treated with the Mock preparation.
PBMC from RV-infected children were stained as described
above, but blocking FcγRs with autologous serum, and stainingNK cells with anti-CD56PE/anti-CD16PE/anti-CD3PerCP (all
from BD Biosciences). The data for RV NSP4 or NSP2
expression was analyzed only when the number of cells for a
given subset was higher than 100.
Detection of cytokines in cell culture supernatants
Frozen supernatants from PBMC exposed to RRV, the Mock
preparation, 2.5 μg/ml SEB or 0.038 μM CpG 2395 were
thawed to measure cytokines according to manufacturer's
instructions. IL-12p70, TNF-α, IL-10, IL-6, IL-1β and IL-8
were evaluated using the cytometric bead array (CBA)
inflammation kit (BD Biosciences) and IFN-γ, IL-4, IL-5 and
IL-2 with the Th1/Th2 CBA kit (BD Biosciences). The CBAs
detected between 1.9 and 7.2 pg/ml of cytokines. ELISA kits
were used for quantifying TGF-β (Duoset, R&D systems,
Minneapolis, MN) and IFN-α (PBL Biomedical Laboratories,
Piscataway, NJ), following the manufacturer's instructions. The
assays detected 31.2 pg/ml of TFG-β and 10 pg/ml of IFN-α.
Results are expressed as net values: cytokine level in PBMC
exposed to RRV minus cytokine level in PBMC exposed to
Mock. For some experiments PBMC were depleted of pDC
with the BDCA-2 isolation kit (Miltenyi Biotec Inc, Auburn,
CA) following the manufacturer's instructions. As control
experiments PBMC were treated with GAM beads (Myltenyi)
or depleted of B cells using anti-CD19 immunomagnetic
microbeads (Miltenyi). Depletion of B cells or pDC was
confirmed by staining the resultant population with anti-
CD19PE and Lin-1FITC/anti-HLA-DRPerCP/anti-CD123PE,
respectively. In both cases the cell subset reductions were higher
than 85%.
Simultaneous detection of viral NSP4 and IFN-α in pDC
PBMC treated with RRVor Mock control were incubated for
8 h at 37 °C. To improve detection of IFNα, 10 μg/ml Brefeldin
A (Sigma) was added during the last 3 h (Dai et al., 2004; Krug
et al., 2001). Then, cells were washed, fixed, permeabilized and
stained as described above for detection of NSP4. Cells were
washed, resuspended in staining buffer and incubated overnight
at 4 °C. The next day, cells were washed with cold 5% fetal calf
serum (FCS, Gibco-BRL) in PBS, blocked with 10 μl FcγR
blocking reagent (Miltenyi) for 10 min at RTand incubated with
0.38 μg MAb anti-IFN-αFITC (PBL) or IgG1FITC isotype
control (BD Biosciences) for 30 min at 4 °C. Then, cells were
washed and incubated 30 min at 4 °C with anti-CD123PE and
anti-HLA-DRPerCP. Finally, cells were washed, fixed with 1%
paraformaldehyde in PBS and analyzed by flow cytometry.
Detection of circulating memory IFN-γ+ RV specific T cells
Frequencies of circulating memory RV-specific CD4+ and
CD8+ cells were determined as previously described (Jaimes et
al., 2002). Briefly, 2×106/2 ml total PBMC, pDC cells-depleted
PBMC, or B-depleted PBMC were incubated with RRV lysate
(MOI=5) or Mock lysate, in the presence of anti-CD49d MAb
0.5 μg/ml (BD Biosciences) and anti-CD28 MAb 0.5 μg/ml
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added after 5 h of incubation. Cells then were washed, fixed and
permeabilized as previously described, and incubated with
MAbs anti-IFN-γFITC or IgG1FITC isotype control, anti-
CD69PE, anti-CD4PerCP and anti-CD8APC (all from BD
Biosciences), for 30 min at 4 °C. Cells were then washed,
resuspended in 1% paraformaldehyde and analyzed by flow
cytometry. CD69 is a marker of recently activated T cells and is
used to identify recently in vitro activated memory T cells
(Jaimes et al., 2002). Results are expressed as the net
percentages of CD69+/CD4+ or CD69+/CD8+ cells expressing
IFN-γ after subtracting values observed in the Mock control
treated PBMC.
ELISAs for measuring RV antigen and RV specific IgA
The presence of RV antigen in feces was determined by
using an enzyme-linked immunosorbent assay (ELISA)
previously described (Jaimes et al., 2002). A supernatant
from RF virus-infected MA104 cells was used as a positive
control and a known RV negative human fecal specimen was
used as a negative control in each plate. Results are expressed
as percentage of reactivity referred to the positive control. For
detection of RV antigen in plasma and PBMC, the same
protocol described was followed, with minor modifications:
plasma samples were diluted in Blotto 2.5% and non diluted
PBMC lysates were used (Crawford et al., 2006), and three
instead of five washes were made.
RV-specific IgA in plasma were detected by ELISA, as
previously described (Gonzalez et al., 2003).
Nucleic acid extraction and P typing RT-PCR
All stool samples were used for nucleic acid extraction and P
genotyping. Double-stranded RNA (dsRNA) was extracted
from 10% stool suspensions in Phosphate-Buffered Saline with
a QIA Amp Viral RNA Kit (Qiagen, Hilden, Germany),
according to the manufacturer's protocol. P typing employed
nested, multiplex RT-PCR and used consensus and type-specific
primers described previously (Gentsch et al., 1992). Consensus
primers Con2 and Con3 were used in a first round RT-PCR (40
cycles) to generate a 876-bp fragment of gene 4; Con3 was then
used in a second round PCR (40 cycles) with types-specific
primers P[8] (1-T1), (VP4NAC10), (VP4NAC25), P[4] (2-T1)
and P[6] (3-T1). The amplified products were detected by
electrophoresis on a 2% agarose gel containing ethidium
bromide (0.5 μg/ml), and visualized under ultra violet
illumination (Gentsch et al., 1992).
Statistical analysis
Statistical analysis was performed with Prisma software
version 3.02, using non-parametric tests. Differences between
groups were evaluated by Mann–Whitney tests. Differences
between paired results within a study group were compared
with the Wilcoxon test. Correlations between groups were
analyzed with Spearman's test. Significance was established ifpb0.05. Data are shown as median, range, unless otherwise
noted.
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